CLEC4G, a glycan-binding receptor, has previously been demonstrated to inhibit Aβ generation, yet its brain localization and functions in Alzheimer’s disease (AD) are not clear. Here, CLEC4G is linked to early-onset autosomal dominant Alzheimer disease.